Xeris Biopharma Inc. (XERS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Xeris Biopharma Inc.

    NASDAQ: XERS · Real-Time Price · USD
    8.20
    -0.11 (-1.32%)
    At close: Oct 03, 2025, 3:59 PM
    8.16
    -0.49%
    Pre-market: Oct 06, 2025, 04:00 AM EDT

    Xeris Biopharma Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -9.07 -5.2 -1.91 -1.89
    PEG Ratio
    		 0.51 0.15 0.03 0.07
    PS Ratio
    		 2.45 1.97 1.64 4.67
    PB Ratio
    		 -16.8 -47.71 3.99 2.43
    P/FCF Ratio
    		 -13.15 -6.56 -1.74 -2.24
    P/OCF Ratio
    		 -13.45 -6.88 -1.75 -2.25
    OCF/S Ratio
    		 -0.18 -0.29 -0.93 -2.07
    Debt / Equity Ratio
    		 -9.17 -33.79 4.38 0.92
    Quick Ratio
    		 1.19 1.23 2.20 1.57
    Current Ratio
    		 1.67 1.64 2.54 1.80
    Asset Turnover
    		 0.63 0.51 0.32 0.14
    Interest Coverage
    		 -1.01 -1.65 -5.81 -16.04
    Return on Equity
    		 1.85 9.18 -2.09 -1.29
    Return on Assets
    		 -0.17 -0.19 -0.27 -0.36
    Return on Invested Capital
    		 -0.13 -0.18 -0.29 -0.52
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.82 0.83 0.79 0.73
    Net Profit Margin
    		 -0.27 -0.38 -0.86 -2.47
    Pretax Profit Margin
    		 -0.28 -0.39 -0.87 -2.47
    Operating Profit Margin
    		 -0.17 -0.27 -0.74 -2.32
    FCF Margin
    		 -0.19 -0.3 -0.94 -2.09
    EBITDA Margin
    		 -0.07 -0.14 -0.63 -2.29

    Add to Watchlist